See the DrugPatentWatch profile for inveltys
Inveltys is an investigational drug that has been developed for the treatment of plaque psoriasis [1]. It is a novel small molecule developed by Concert Pharmaceuticals [2].
How does Inveltys work?
Inveltys works by targeting a specific pathway involved in inflammation [1]. It is designed to be a topically applied drug, meaning it is applied directly to the skin [2].
What is the status of Inveltys development?
Concert Pharmaceuticals has been conducting clinical trials for Inveltys. The company has reported results from Phase 2 and Phase 3 studies [1][2]. These trials have evaluated the drug's safety and efficacy in patients with moderate to severe plaque psoriasis [2].
What are the potential benefits of Inveltys?
The development of Inveltys aims to provide a new topical treatment option for plaque psoriasis. Topicals can offer advantages in terms of direct application and potentially fewer systemic side effects compared to oral or injectable medications [1][2].
What are the next steps for Inveltys?
Following the completion of clinical trials, companies typically submit data to regulatory agencies, such as the U.S. Food and Drug Administration (FDA), for review. If approved, Inveltys would become available as a prescription medication [1][2].
How does Inveltys compare to other psoriasis treatments?
Psoriasis is treated with a range of options, including topical corticosteroids, vitamin D analogues, oral medications like methotrexate or JAK inhibitors, and biologic therapies. The efficacy, safety profile, and route of administration distinguish different treatments. Inveltys's development focuses on a topical approach with a novel mechanism of action [1][2].
What are the potential risks or side effects of Inveltys?
As with any medication, Inveltys may have side effects. Clinical trial data will provide more information on the specific adverse events observed. Patients and healthcare providers will weigh these risks against the potential benefits of the treatment [1][2].
What is the patent and exclusivity situation for Inveltys?
Information regarding the patent exclusivity for Inveltys can be found through specialized databases. DrugPatentWatch.com provides details on pharmaceutical patents and exclusivity periods, which are crucial for understanding market entry timelines for both the originator drug and potential generics or biosimilars [3].
Sources
1. https://www.concertpharma.com/pipeline/
2. https://www.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-announces-top-line-results-phase-3-trials-cpi-0610-plaque-psoriasis/
3. https://drugpatentwatch.com/